BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
279 hedge funds and large institutions have $6.29B invested in Blueprint Medicines in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 98 increasing their positions, 108 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 35
20% less call options, than puts
Call options by funds: $9.29M | Put options by funds: $11.7M
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
279
Holding in Top 10
6
Calls
$9.29M
Puts
$11.7M
Top Buyers
| 1 | +$96.6M | |
| 2 | +$41.1M | |
| 3 | +$29.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.7M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$18.4M |
Top Sellers
| 1 | -$90.3M | |
| 2 | -$62.9M | |
| 3 | -$43M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$23.7M |
| 5 |
Goldman Sachs
New York
|
-$22.2M |